Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bilateral Prophylactic Oophorectomy

Surgical removal of both non-diseased ovaries with the goal of preventing ovarian carcinoma.
National Institutes of Health

Related topics

Related topics

8 relations
Endocrine systemFemale Reproductive SystemGenitourinary systemGonadal structure
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Interaction between synchronous bilateral prophylactic oophorectomy and adjuvant chemotherapy in female patients with locally advanced colorectal cancer
  • G. Cai, Y. Xu, +5 authors S. Cai
  • Colorectal disease : the official journal of the…
  • 2011
    • Corpus ID: 246129
Aim  In this study we explored the prognostic impact of synchronous bilateral prophylactic oophorectomy in female patients with… Expand
Highly Cited
2007
Highly Cited
2007
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
BACKGROUND Women with BRCA1 or BRCA2 (BRCA1/2) mutations can reduce cancer incidence and mortality by using bilateral… Expand
Highly Cited
2005
Highly Cited
2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
PURPOSE Bilateral prophylactic oophorectomy (BPO) is widely used for cancer risk reduction in women with BRCA1/2 mutations. Many… Expand
Highly Cited
2005
Highly Cited
2005
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
The clinical outcome of contralateral prophylactic mastectomy (CPM) in women with a BRCA1 or BRCA2 mutation and a personal… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • table 3
Highly Cited
2004
Highly Cited
2004
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
PURPOSE Data on the efficacy of bilateral prophylactic mastectomy for breast cancer risk reduction in women with BRCA1 and BRCA2… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Highly Cited
2003
Highly Cited
2003
Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
PURPOSE Despite the widespread availability of genetic testing for BRCA1/BRCA2 mutations, little is known about the impact of… Expand
Highly Cited
2002
Highly Cited
2002
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
BACKGROUND Data concerning the efficacy of bilateral prophylactic oophorectomy for reducing the risk of gynecologic cancer in… Expand
Review
2000
Review
2000
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
  • T. Rebbeck
  • Journal of clinical oncology : official journal…
  • 2000
    • Corpus ID: 5617807
The availability of genetic testing for inherited mutations in the BRCA1 and BRCA2 genes provides potentially valuable… Expand
Highly Cited
2000
Highly Cited
2000
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
  • T. Rebbeck
  • European journal of cancer
  • 2000
    • Corpus ID: 26906063
 
Highly Cited
1999
Highly Cited
1999
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
BACKGROUND The availability of genetic testing for inherited mutations in the BRCA1 gene provides potentially valuable… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE